Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages

Oliver, B. G. G.; Lim, S.; Wark, P.; Laza-Stanca, V.; King, N.; Black, J. L.; Burgess, J. K.; Roth, M.; Johnston, S. L.
June 2008
Thorax;Jun2008, Vol. 63 Issue 6, p519
Academic Journal
Background: Rhinovirus infection is responsible for considerable morbidity and mortality as the major cause of exacerbations of asthma, and is also known to induce exacerbations of cystic fibrosis and chronic obstructive pulmonary disease. Exacerbations of these diseases are also frequently associated with bacterial and atypical bacterial infection. Alveolar macrophages are the major immune cells ill the airways and are important in defence against bacterial infections. Methods: The authors investigated whether rhinovirus modifies cytokine release, the pattern recognition receptor expression and phagocytosis by human alveolar macro- phages in response to bacterial products. Results: Viable rhinovirus was detected in macrophages up to 3 days after exposure and viral RNA expression persisted for 10 days. Infectious but not UV inactivated rhinovirus increased tumour necrosis factor α (TNFα) and interleukin (lL)8 release by macrophages. In contrast, infectious rhinovirus impaired lipopolysaccharide and lipoteichoic acid induced TNFα and IL8 secretion by macrophages. Rhinovirus induced impairment of macrophage antibacterial immune responses did not involve IL10, prostaglandin E2 or downregulation of Toll-like receptor 2. Furthermore, the macrophage phagocytic response to labelled bacterial particles, but not to latex beads, was impaired. Conclusion: The authors have identified impairment of cytokine responses to bacterial lipopolysaccharide and lipoteichoic acid by alveolar macrophages in response to infectious rhinovirus. Virus induced impairment of antibacterial host defence has important implications in the pathogenesis of exacerbations of respiratory diseases.


Related Articles

  • Role of microRNAs in lung development and pulmonary diseases. Sessa, Roberto; Hata, Akiko // Pulmonary Circulation;Apr-Jun2013, Vol. 3 Issue 2, p315 

    MicroRNAs (miRNAs) are a class of small noncoding RNA which exert post-transcriptional gene regulation activity by targeting messenger RNAs. miRNAs have been found to be involved in various fundamental biological processes and deregulation of miRNAs is known to result in pathological conditions....

  • Paediatric respiratory mortality: past triumphs, future challenges. Russell, G. // Thorax;Dec2005, Vol. 60 Issue 12, p985 

    The article presents information related to paediatric respiratory mortality. The improving mortality from pneumonia reflects many medical advances other than new antibiotics. However, pneumonia is not the only important cause of respiratory mortality in children. Although fewer than 5% of...

  • Interaction of TGF-β with Immune Cells in Airway Disease. Moore, Benjamin; Murphy, Richard F.; Agrawal, Devendra K. // Current Molecular Medicine;Aug2008, Vol. 8 Issue 5, p427 

    Asthma, chronic obstructive pulmonary disorder (COPD), and cystic fibrosis (CF), chronic diseases of the airways, are characterized by symptoms such as inflammation of the lung tissue, mucus hypersecretion, constriction of the airways, and excessive fibrosis of airway tissue. Transforming growth...

  • CASE 1 DIAGNOSIS: CYSTIC FIBROSIS. Luu, Kelly // Paediatrics & Child Health (1205-7088);Oct2011, Vol. 16 Issue 8, p466 

    The article presents the case study of a patient cystic fibrosis (CF) mutations. Genetic analysis of the patient identified no testable cystic fibrosis (CF) mutations. It was concluded that CF is the most common genetic condition that affect Caucasians. It is noted that misdiagnosis of asthma is...

  • Sex differences in mouse models of asthma. Chang, Herng-Yu Sucie; Mitzner, Wayne // Canadian Journal of Physiology & Pharmacology;Dec2007, Vol. 85 Issue 12, p1226 

    Differences in disease susceptibility and prognosis between men and women are known to occur in the incidence and development of neurodegenerative, cardiovascular, and immunological disorders. In the lung there are also sex-based differences in the incidence, prevalence, and pathogenesis of lung...

  • Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Horsley, A. R.; Gustafsson, P. M.; Macleod, K. A.; Saunders, C.; Greening, A. P.; Porteous, D. J.; Davies, J. C.; Cunningham, S.; Alton, E. W. F. W.; Innes, J. A. // Thorax;Feb2008, Vol. 63 Issue 2, p135 

    Background: Lung clearance index (LCI) is a sensitive marker of early lung disease in children but has not been assessed in adults. Measurement is hindered by the complexity of the equipment required. The aims of this study were to assess performance of a novel gas analyser (Innocor) and to use...

  • Following Nero: fiddle while Rome burns, or is there a better way? Bush, Andrew; Pavord, Ian // Thorax;May2011, Vol. 66 Issue 5, p367 

    The author comments on the use of the term exacerbation in describing severity of asthma or chronic obstructive pulmonary disease in relation to a proposal to discard the term in favor of the phrase lung attack. The author criticizes the generally accepted view of exacerbation and discusses how...

  • Macrophage enrichment from induced sputum. Sikkeland, Liv I. B.; Kongerud, Johny; Stangeland, Astrici M.; Haug, Terje; Alexis, Neil E.; Stangeland, Astrid M // Thorax;Jun2007, Vol. 62 Issue 6, p558 

    The article discusses a study which demonstrates the capability to isolate sputum macrophages in asthma patients, to advance our understanding of macrophage biology in the airways. The techniques for isolating and enriching macrophages in sputum were compared. The magnetic bead isolation...

  • Targeted delivery of magnetic aerosol droplets to the lung. Dames, Petra; Gleich, Bernhard; Flemmer, Andreas; Hajek, Kerstin; Seidl, Nicole; Wiekhorst, Frank; Eberbeck, Dietmar; Bittmann, Iris; Bergemann, Christian; Weyh, Thomas; Trahms, Lutz; Rosenecker, Joseph; Rudolph, Carsten // Nature Nanotechnology;Aug2007, Vol. 2 Issue 8, p495 

    The inhalation of medical aerosols is widely used for the treatment of lung disorders such as asthma, chronic obstructive pulmonary disease, cystic fibrosis, respiratory infection and, more recently, lung cancer. Targeted aerosol delivery to the affected lung tissue may improve therapeutic...


Read the Article


Sign out of this library

Other Topics